Iris Latorre
About Iris Latorre
Iris Latorre is the Associate Director of Compliance & Risk Management for the Investigational Material Supply Chain at Bristol-Myers Squibb, with over 25 years of experience in the pharmaceutical industry.
Company
Iris Latorre currently works at Bristol-Myers Squibb as the Associate Director, Compliance & Risk Management, Investigational Material Supply Chain. She has been integral in this role since 2019 following the acquisition of Celgene by Bristol-Myers Squibb. This role is focused on ensuring compliance and managing risks associated with investigational material supply chains. She works at the company's location in Summit, New Jersey.
Title
Iris Latorre holds the title of Associate Director, Compliance & Risk Management, Investigational Material Supply Chain at Bristol-Myers Squibb. In this capacity, she specializes in monitoring and managing compliance and risk aspects related to the investigational materials used in clinical trials.
Education and Expertise
Iris Latorre earned her PharmD in Clinical Pharmacy from the University of the Sciences in Philadelphia, where she studied from 1992 to 1994. Additionally, she holds a BSc in Pharmacy from the University of Puerto Rico, where she studied from 1985 to 1991. With over 25 years of experience in the pharmaceutical industry, particularly in compliance and risk management for investigational material supply chains, she brings a wealth of knowledge to her current role.
Background
Iris Latorre began her career at Merck-Frosst Canada as Associate Director, Global Clinical Supplies Operations, a role she held for 12 years. From 2007 to 2010, she was self-employed as a Clinical Supplies Consultant. She then spent eight years at Celgene as Associate Director, Compliance & Risk Management, Investigational Material Supply Chain, before transitioning to Bristol-Myers Squibb in 2019.
Achievements
Iris Latorre has played a pivotal role in managing compliance and risk for investigational materials, particularly during the merger of Celgene and Bristol-Myers Squibb. Her extensive expertise in global clinical supplies operations and risk management has positioned her as a key figure in ensuring the integrity of clinical trial materials across her career.